Monoctanoin

Monoctanoin
Clinical data
Trade names	Moctanin
Other names	1-Mono-octanoin; glycerol monoctanoate; 1-monocaprylin; 1-monocapryloyl-rac-glycerol; 1-monooctanoin; 1-monooctanoylglycerol; caprylic acid α-monoglyceride; DL-1-monooctanoin; glyceryl 1-monooctanoate; octanoic acid 1-monoglyceride; α-monocaprylin
AHFS/Drugs.com	Micromedex Detailed Consumer Information
Routes of; administration	Injection through catheter into bile duct
ATC code	None;
Legal status
Legal status	Discontinued;
Identifiers
	IUPAC name 2,3-Dihydroxypropyl octanoate;
CAS Number	502-54-5;
PubChem CID	3033877;
DrugBank	DB06801;
ChemSpider	2298454;
UNII	VFU0OU98LO;
KEGG	D05073;
CompTox Dashboard (EPA)	DTXSID6048383 ;
ECHA InfoCard	100.112.381
Chemical and physical data
Formula	C11H22O4
Molar mass	218.293 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(OCC(O)CO)CCCCCCC;
	InChI InChI=1S/C11H22O4/c1-2-3-4-5-6-7-11(14)15-9-10(13)8-12/h10,12-13H,2-9H2,1H3; Key:GHBFNMLVSPCDGN-UHFFFAOYSA-N;

Monoctanoin (or monocaprylin; trade name Moctanin) is a monoglyceride used to dissolve gallstones consisting of cholesterol. It is not available in the US any more.^[1]

The drug was given by injection through a catheter into the bile duct. Its most common adverse effects were abdominal or stomach pain, usually mild, or a burning sensation.^[1]

References

^ ^a ^b Monoctanoin (Injection) Micromedex Detailed Consumer Information. Accessed 28 April 2021.

This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.

[cons-1] Monoctanoin (Injection) Micromedex Detailed Consumer Information. Accessed 28 April 2021.

[1]